High potency medicines are very useful as it uses small molecules so that healthcare provider can provide better treatment and therapies to the patients. These medicines consist of highly potent active pharmaceutical ingredients that not only need less dosage but are very effective. These high potency medicines are changing the pharmaceutical industry scenario as many manufacturers are using these medicines so that they can provide treatment for the diseases like cancers, respiratory problems etc. Presence of active pharmaceutical ingredients and rising demand for better treatment among patients is the factor due to which has increased the demand for high potency medicines. Encore Dermatology Inc. announced the launch of their new product IMPOYZ Cream which is specially designed for the patient with serious plaque psoriasis. It is the only cream FDA- approved high potency topical corticosteroid which consist of 0.025% of clobetasol propionate. As per Bob Moccia, president and CEO of Encore Dermatology, ‘with this launch of IMPOYZ cream, now dermatology providers will get a substitute for the traditional clobetasol which will be very beneficial for them as now they can treat their patient with a lower concentration. Clobetasol propionate traditionally had been only available in one variation/potency since the last three decades. This new cream has clobetasol propionate which is its active ingredient. Clobetasol propionate is a kind of a corticosteroid which is mainly used to cure skin conditions like psoriasis, eczema, seborrheic dermatitis and contact dermatitis. They are usually available in the form of cream, shampoo or ointment so that they can be applied on the skin easily. They are used to avoid skin conditions like pimples, redness, skin irritation etc. IMPOYZ cream consists of clobetasol propionate 0.025% and is very useful as they have the ability to reduce symptoms of the plaque psoriasis. These new creams have the ability to provide better tolerability and safety. Psoriasis is a skin condition that increases the formation of skin cell and these extra skin cells create red patches which usually causes irritation, redness and pain. This is the reason; it is very difficult to treat these patients as psoriasis somewhere affects their day to day life. According to Mark Lebwohl, MD, Professor and Chairman of the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai, ‘With this new formulation, today health providers can easily treat patient, whether they are in moderate or serious condition.’ Encore Dermatology is very happy with the new launch because this will help them to provide better treatment and solution to the patients with psoriasis. This new cream can also be used with the other products of the encore dermatology so that they can cure skin problems like acne and eczema. As there are only few medical companies in the market who are launching such innovative products, this will help the company to strengthen them in the market.
